Home Medicine Integration of Traditional, Complementary, and Integrative Medicine (TCIM) in the Institutionalization of Evidence-Informed Decision-making

Integration of Traditional, Complementary, and Integrative Medicine (TCIM) in the Institutionalization of Evidence-Informed Decision-making

by Universalwellnesssystems

2024 Prince Mahidol Awards Conference Hybrid Side Event

January 23, 2024, Bangkok, Thailand

The WHO Policy and Impact Evidence Unit (Health Sector Research) and the WHO Center for Global Traditional Medicine Evidence Unit are hosting a joint side event to examine the state of the evidence at the 2024 Prince Mahidol Prize Conference (PMAC). Masu. Institutionalizing global informed policy making (EIDM) and traditional, complementary, and integrative approaches in promoting inclusivity, health equity, epistemic justice, and decolonial global health governance. Meaning of intersection with medical care (TCIM). This side event will explore potential mechanisms (infrastructures, conditions and frameworks) to enhance the use of evidence in global policy development towards realizing TCIM's contribution to health and well-being.

The use of evidence in policy and decision-making has increased exponentially and is now considered standard practice within health systems. However, a gap between research and practice still exists. WHO supports advanced initiatives to promote the institutionalization of evidence-based decision-making/policy-making (EIDM), such as the Evidence-Based Policy Network (EVIPNet), and to support the routine use of evidence in disaster situations. We offer tools such as the WHO checklist. Policy-making process. The checklist is currently being pilot tested to assess its effectiveness and feasibility, and includes six areas: Governance, Standards and Routine Processes, Leadership and Commitment, Resources and Capacity Building/Enhancing, Partnerships, collective action, support, and culture). Five processes of EIDM institutionalization.

The Gujarat Declaration of the 1st WHO World Traditional Medicine Summit (August 17-18, 2023, Gandhinagar, India) articulated guidelines for action, including a focus on research and evidence. The report recommended “appropriate use of existing and new research, principles of evidence synthesis and knowledge translation, and WHO initiatives.” It will also strengthen capacity to “produce, translate and utilize TCIM research and indigenous knowledge” and ensure “the evidence-based integration of TCIM into national health policies and systems based on the highest quality research.” He also recommended support.

This side event is a first step towards moving forward with the Gujarat Declaration's evidence-related proposals, and the progress and challenges of integrating TCIM in global EIDM institutionalization, as well as the conditions needed to strengthen it. is intended to evaluate.

For more information on side events, please visit the PMAC website.

https://pmac2024.com/activity/73/sidemeetingOnsite/detail

Registration:

Side event agenda:

Welcome and introduction: Tanja Kuchenmüller, Unit Head, Policy Evidence and Implications Unit, Health Research Division, Science Division, WHO.

Session A. Overview of WHO-led EIDM initiatives and country-level examples.

Session Chair: Laurenz Mahlanza-Langer, Director General, Pan-African Evidence Collective (PACE), South Africa.

  1. WHO-led efforts on EIDM institutionalization and public participation. Tanya Kuchenmuller.
  2. Supporting the routine use of evidence in policy making: A pilot study of the World Health Organization's EIDM checklist. Mukdarut Banpan, Associate Professor of Evidence-Based Policy and Development, University College London, UK.
  3. Approaches to EIDM institutionalization and public participation: Country development, barriers and facilitators:
    • Thailand: Involving the public in evidence-based policy making. Tipicha Posayanonda, Director of Knowledge and Innovation Management, Office of the National Health Commission of Thailand.
    • BrazilIn: Promoting synergies in EIDM: Engaging the public sector, academia, and civil society. Laura dos Santos Boeira, Executive Director of the Brazil Veredas Institute.
  4. Comments on the impact of incorporating TCIM into EIDM institutionalization and public participation efforts: Ms. Anchalee Chutaputti, Advisor (International Cooperation), Thai Department of Traditional and Alternative Medicine. Mariana Cabral Schweitzer, Adjunct Professor, Department of Preventive Medicine, Federal University of São Paulo, Brazil.
  5. Q&A

Session B. Assessment of the world situation / Critical analysis of the translation of TCIM-related knowledge and the incorporation of TCIM into the EDIM process.

Session Chair: Amy Steele, Associate Professor, Australian Complementary and Integrative Medicine Research Consortium, School of Health, University of Technology Sydney, Australia.

  1. An overview of the principles of the Gujarat Declaration and the WHO GTMC evidence workstream. Geetha Krishnan G. Pillai, Head of Evidence Unit, GTMC, WHO World Traditional Medicine Center.
  2. Implications of TCIM integration in EIDM: Proposal for a new WHO 2025-2034 TCIM global strategy. Mr. Liu Qin, Technical Director, Traditional, Complementary, and Integrative Medicine Division, WHO Integrative Health Services Division.
  3. Implications for epistemic pluralism, epistemic justice, and decolonial EIDM in TCIM. Nadine Ijaz, Assistant Professor, Faculty of Law, Carleton University, Canada.
  4. Translating traditional knowledge and re-indigenizing clinical practice, research, policy and education. Alana Gal, Co-Vice Chair of the World Public Health Association Federation of Indigenous Peoples Working Group and Representative of Indigenous Traditional Medicine to the Coordinating Council for Traditional, Complementary and Integrative Medicine, People's Declaration for Traditional, Complementary and Integrative Medicine.
  5. Empowering communities through TCIM-based policies. Darshan Shankar, President, Interdisciplinary University, Bangalore, India.
  6. Participatory panel (all presenters): Progress and challenges in translating traditional and indigenous therapeutic knowledge systems into policy.

Session C. Participatory workshop proposing next steps to address known research and practice gaps for including TCIM in EIDM

Workshop co-facilitators: Mukdarut Banpan, Associate Professor of Evidence-Based Policy and Development, University College London, UK. Amy Steele, Associate Professor, Australian Complementary and Integrative Medicine Research Consortium, School of Health, University of Technology Sydney, Australia. Daniel F. Gallego-Perez, Postdoctoral Fellow, University of North Carolina at Chapel Hill, USA.

You may also like

Leave a Comment

The US Global Health Company is a United States based holistic wellness & lifestyle company, specializing in Financial, Emotional, & Physical Health.  

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

Copyright ©️ All rights reserved. | US Global Health